Rewalk Robotics (RWLK) Receives Daily Coverage Optimism Rating of 0.18

Media stories about Rewalk Robotics (NASDAQ:RWLK) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rewalk Robotics earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news coverage about the medical device company an impact score of 45.7922351793357 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the media stories that may have impacted Accern Sentiment’s scoring:

Shares of Rewalk Robotics (NASDAQ:RWLK) traded down $0.05 during midday trading on Thursday, hitting $1.05. The company had a trading volume of 215,806 shares, compared to its average volume of 275,611. The company has a quick ratio of 1.65, a current ratio of 2.02 and a debt-to-equity ratio of 7.46. The firm has a market cap of $30.37, a PE ratio of -0.66 and a beta of 0.83. Rewalk Robotics has a twelve month low of $1.05 and a twelve month high of $3.20.

Several brokerages have recently issued reports on RWLK. Zacks Investment Research upgraded Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price target on the stock in a research report on Thursday, November 9th. Canaccord Genuity reiterated a “buy” rating and set a $3.00 price target on shares of Rewalk Robotics in a research report on Monday, November 6th. Jefferies Group lowered their price target on Rewalk Robotics from $8.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, November 3rd. Piper Jaffray Companies reiterated a “buy” rating and set a $3.00 price target on shares of Rewalk Robotics in a research report on Sunday, January 7th. Finally, ValuEngine upgraded Rewalk Robotics from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $2.83.

WARNING: This piece was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at

Rewalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Insider Buying and Selling by Quarter for Rewalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit